Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Wolf Peter"

From Bioblast
 
Line 2: Line 2:
|lastname=Wolf
|lastname=Wolf
|firstname=Peter
|firstname=Peter
|title=Dr. Chief Scientific Officer (CSO) and Head of Assay Development
|title=Dr.  
|institution=[[File:Dr. Peter Wolf.jpg|right|180px|Peter Wolf]] INCYTON GmbH Innovation and Start-Up Center for Biotechnology
Chief Scientific Officer (CSO) and Head of Assay Development
|institution=[[File:Dr. Peter Wolf.jpg|right|180px|Peter Wolf]] INCYTON GmbH,
 
Innovation and Start-Up Center for Biotechnology
|address=Am Klopferspitz19A
|address=Am Klopferspitz19A
|area code=82152
|area code=82152

Latest revision as of 09:54, 14 April 2022

Name Wolf Peter, Dr.

Chief Scientific Officer (CSO) and Head of Assay Development

Institution
Peter Wolf
INCYTON GmbH,

Innovation and Start-Up Center for Biotechnology

Address Am Klopferspitz19A, 82152
City Planegg/Martinsried
State/Province
Country Germany
Email peter.wolf@incyton.com
Weblink https://www.incyton.com/
O2k-Network Lab


Labels:



Publications

 PublishedReference
Heichler 2022 MitoFit2022Heichler C, Nagy M, Wolf P (2022) Evaluation of hepatotoxic effects of acetaminophen on HepG2 cells by parallel real-time monitoring in a multi-sensor analysis platform for automated cell-based assays. https://doi.org/10.26124/mitofit:2022-00062022-07-06 published in Bioenerg Commun 2022.6.
Heichler 2022 BEC2022Heichler C, Nagy M, Wolf P (2022) Evaluation of hepatotoxic effects of acetaminophen on HepG2 cells by parallel real-time monitoring in a multi-sensor analysis platform for automated cell-based assays. Bioenerg Commun 2022.6. https://doi.org/10.26124/bec:2022-0006

Abstracts

 PublishedReference
Wolf 2022 Abstract Bioblast20225.4. «10+5»
Wolf Peter
Heichler C, Nagy M, Wolf Peter (2022) Physiometabolic RTCA on an automated platform for short and long term applications. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001
»Bioenergetics Communications« »Watch the presentation«